Exelead inks deal to manufacture lipid nanoparticles for Pfizer/BioNTech vaccine
For the two leading Covid-19 vaccines, mRNA is the star of the show — and the microscopic lipids used to transport that therapy into cells have …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
